Men's health study - Epidemiology of erectile dysfunction and cardiovascular disease

被引:0
|
作者
Sasayama, S
Ishii, N
Ishikura, F
Kamijima, G
Ogawa, S
Kanmatsuse, K
Kimoto, Y
Sakuma, I
Nonogi, H
Matsumori, A
Yamamoto, Y
机构
[1] Hamamatsu Rosai Hosp, Shizuoka 4308525, Japan
[2] Toho Univ, Sch Med, Dept Urol 1, Tokyo, Japan
[3] Osaka Univ, Fac Med, Sch Allied Hlth Sci, Osaka, Japan
[4] Toho Univ, Sch Med, Dept Internal Med 2, Tokyo, Japan
[5] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan
[6] Nihon Univ, Sch Med, Dept Internal Med 2, Tokyo 173, Japan
[7] Spinal Injuries Ctr, Dept Urol, Fukuoka, Japan
[8] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido 060, Japan
[9] Natl Cardiovasc Ctr, Osaka, Japan
[10] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan
[11] Nippon Med Coll, Dept Emergency & Crit Care Med, Tokyo 113, Japan
关键词
cardiovascular disease; comorbidity; endothelium; erectile dysfunction; risk factors; INTERNATIONAL INDEX; SILDENAFIL;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study collected data about 6,112 Japanese male patients from 447 outpatient clinics. Of those who underwent medical examination by a general practitioner on an outpatient basis, up to 81% had some degree of erectile dysfunction (ED), ranging from mild to severe. ED was noted to be predominant among patients affected by cardiovascular disease (CVD) or diabetes mellitus (DM), and the presence of CVD increased the risk of ED. In an aging society, patients undergoing treatment for ED as part of their routine medical care are highly likely to have concomitant CVD. As shown in the present survey, clinicians need to be aware of the high incidence of ED among such patients, because ED represents a symptom originating from damage to the vascular endothelium. A total of 41% of ED patients are either willing to receive pharmacotherapy for ED or will consider treatment. Active treatment of ED with sildenafil is suitable for patients with CVD.
引用
收藏
页码:656 / 659
页数:4
相关论文
共 50 条
  • [41] Efficacy and Safety of Sildenafil by Age in Men With Erectile Dysfunction
    Goldstein, Irwin
    Tseng, Li-Jung
    Creanga, Dana
    Stecher, Vera
    Kaminetsky, Jed C.
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : 852 - 859
  • [42] Does erectile dysfunction predict cardiovascular risk? A cross-sectional study of clinical characteristics in patients with erectile dysfunction combined with coronary heart disease
    Li, Luyu
    Zhang, Yongtao
    Ma, Miaomiao
    Liu, Feng
    Shang, Yihan
    Yuan, Quan
    Li, Xiao
    Ju, Baojun
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [43] Erectile Dysfunction in Men Burdened with the Familial Occurrence of Coronary Artery Disease
    Kalka, Dariusz
    Gebala, Jana
    Biernikiewicz, Malgorzata
    Mrozek-Szetela, Aneta
    Rozek-Piechura, Krystyna
    Sobieszczanska, Malgorzata
    Szuster, Ewa
    Majchrowska, Marzena
    Mietka, Anna
    Rusiecka, Agnieszka
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (18)
  • [44] Increased erythrocyte aggregation in men with coronary artery disease and erectile dysfunction
    Justo, D.
    Mashav, N.
    Arbel, Y.
    Kinori, M.
    Steinvil, A.
    Swartzon, M.
    Molat, B.
    Halkin, A.
    Finkelstein, A.
    Heruti, R.
    Banai, S.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2009, 21 (03) : 192 - 197
  • [45] Can simvastatin improve erectile function and health-related quality of life in men aged 40 years with erectile dysfunction? Results of the Erectile Dysfunction and Statins Trial [ISRCTN66772971]
    Trivedi, Daksha
    Kirby, Michael
    Wellsted, David M.
    Ali, Shehzad
    Hackett, Geoffrey
    O'Connor, Bernadette
    van Os, Sandra
    BJU INTERNATIONAL, 2013, 111 (02) : 324 - 333
  • [46] Cardiovascular risk stratification and cardiovascular risk factors associated with erectile dysfunction: Assessing cardiovascular risk in men with erectile dysfunction
    Barrett-Connor, E
    CLINICAL CARDIOLOGY, 2004, 27 (04) : I8 - I13
  • [47] Erectile dysfunction links to cardiovascular disease-defining the clinical value
    Orimoloye, Olusola A.
    Feldman, David I.
    Blaha, Michael J.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2019, 29 (08) : 458 - 465
  • [48] Erectile dysfunction in patients with cardiovascular disease and the potential influence of genetic markers
    Ors, Diego
    Segura, Ana
    Arrarte, Vicente
    Ballester, Pura
    Muriel, Javier
    Fernandez, Guillermina
    Soriano, Josefa
    Peiro, Ana M.
    REVISTA INTERNACIONAL DE ANDROLOGIA, 2021, 19 (04): : 217 - 223
  • [49] Erectile Dysfunction as a Marker for Cardiovascular Disease Diagnosis and Intervention: A Cost Analysis
    Pastuszak, Alexander W.
    Hyman, Daniel A.
    Yadav, Naveen
    Godoy, Guilherme
    Lipshultz, Larry I.
    Araujo, Andre B.
    Khera, Mohit
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 (04): : 975 - 984
  • [50] Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes
    Miner, Martin
    Seftel, Allen D.
    Nehra, Ajay
    Ganz, Peter
    Kloner, Robert A.
    Montorsi, Piero
    Vlachopoulos, Charalambos
    Ramsey, Melinda
    Sigman, Mark
    Tilkemeier, Peter
    Jackson, Graham
    AMERICAN HEART JOURNAL, 2012, 164 (01) : 21 - 28